54 related articles for article (PubMed ID: 37844021)
1. Survival Outcomes of Medullary Thyroid Cancer With and Without Amyloid Deposition.
Toraih E; Hussein M; Anker A; Baah S; Pinion D; Jishu J; Sadakkadulla S; Case M; LaForteza A; Moroz K; Kandil E
Endocr Pract; 2024 Apr; 30(4):311-318. PubMed ID: 38184237
[TBL] [Abstract][Full Text] [Related]
2. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
Jin LX; Moley JF
Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
[TBL] [Abstract][Full Text] [Related]
3. [Lymph node excision in thyroid carcinoma].
Dralle H; Gimm O
Chirurg; 1996 Aug; 67(8):788-806. PubMed ID: 8964151
[TBL] [Abstract][Full Text] [Related]
4. Competing-risks model for predicting the prognostic value of lymph nodes in medullary thyroid carcinoma.
Shang F; Liu X; Ren X; Li Y; Cai L; Sun Y; Wen J; Zhai X
PLoS One; 2023; 18(10):e0292488. PubMed ID: 37844021
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma.
Leggett MD; Chen SL; Schneider PD; Martinez SR
Ann Surg Oncol; 2008 Sep; 15(9):2493-9. PubMed ID: 18594930
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of LODDS in medullary thyroid carcinoma based on competing risk model and propensity score matching analysis.
Cao ZX; Weng X; Huang JS; Long X
Updates Surg; 2022 Oct; 74(5):1551-1562. PubMed ID: 35821560
[TBL] [Abstract][Full Text] [Related]
7. Metastatic lymph node ratio can further stratify risk for mortality in medullary thyroid cancer patients: A population-based analysis.
Qu N; Shi RL; Lu ZW; Liao T; Wen D; Sun GH; Li DS; Ji QH
Oncotarget; 2016 Oct; 7(40):65937-65945. PubMed ID: 27588396
[TBL] [Abstract][Full Text] [Related]
8. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study.
Rozenblat T; Hirsch D; Robenshtok E; Grozinsky-Glasberg S; Gross DJ; Mazeh H; Benbassat C; Twito O; Levy S; Mizrachi A; Shpitzer T; Bachar G
Eur J Surg Oncol; 2020 Nov; 46(11):2023-2028. PubMed ID: 32389525
[TBL] [Abstract][Full Text] [Related]
10. Management of lymph nodes in medullary thyroid carcinoma: A review.
Shaghaghi A; Salari A; Jalaeefar A; Shirkhoda M
Ann Med Surg (Lond); 2022 Sep; 81():104538. PubMed ID: 36147070
[TBL] [Abstract][Full Text] [Related]
11. Medullary thyroid carcinoma: a narrative historical review.
Wong A; Nabata K; Wiseman SM
Expert Rev Anticancer Ther; 2022 Aug; 22(8):823-834. PubMed ID: 35694971
[TBL] [Abstract][Full Text] [Related]
12. Inclusion of the Number of Metastatic Lymph Nodes in the Staging System for Medullary Thyroid Cancer: Validating a Modified American Joint Committee on Cancer Tumor-Node-Metastasis Staging System.
Wang Z; Tang C; Wang Y; Yin Z; Rixiati Y
Thyroid; 2022 May; 32(5):536-543. PubMed ID: 35350868
[No Abstract] [Full Text] [Related]
13. Negative lymph node count is an independent prognostic factor for female patients with node positive breast cancer.
Wu H; Huang Y
Transl Cancer Res; 2020 Dec; 9(12):7450-7457. PubMed ID: 35117345
[TBL] [Abstract][Full Text] [Related]
14. Male gender as a poor prognostic factor in medullary thyroid carcinoma: behavior or biological difference?
Costa CS; Souteiro P; Paredes S; Bettencourt-Silva R; Pedro J; Ferreira MJ; Salazar D; Teixeira MR; Oliveira J; Santos AP; Torres I
Minerva Endocrinol (Torino); 2023 Dec; 48(4):395-400. PubMed ID: 35103459
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Performance of Alternative Lymph Node Classification Systems for Patients with Medullary Thyroid Cancer: A Single Center Cohort Study.
Prassas D; Kounnamas A; Cupisti K; Schott M; Knoefel WT; Krieg A
Ann Surg Oncol; 2022 Apr; 29(4):2561-2569. PubMed ID: 34890024
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
